There are currently no events listed.
Latest News
CX 2025: Sirolimus implant fails to meet fistula maturation endpoint in...
Results of the ACCESS 2 study, evaluating arteriovenous fistula (AVF) outcomes following use of the Sirogen (Vascular Therapies) sirolimus-eluting collagen implant, have shown that...
Features
‘Lively’ debate anticipated during CX Vascular Access and Renal Interventions session
A dedicated all-day session at CX 2025 (Wednesday 23 April, Auditorium 3) will address critical challenges in vascular access and renal interventions, featuring multiple...
Tipping the scales with less weight: Why RCTs can be overly...
Ellen Dillavou (WakeMed Heart Center, Raleigh, USA) asks whether the high bar for evidence being sought to bring new de novo devices to market...
Videos
Vascular News editorial board members Nicholas Inston (Birmingham, UK; CX executive board member) and Bart Dolmatch (Palo Alto, USA) are joined by Kate Steiner (Stevenage, UK; CX executive board member) to share their expert insights on a range of...
